JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Michele Di Mauro
Antonio Bivona
Antonio M. Calafiore
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Di Mauro, M.
Right arrow Articles by Calafiore, A. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Di Mauro, M.
Right arrow Articles by Calafiore, A. M.
Related Collections
Right arrow Coronary disease

J Thorac Cardiovasc Surg 2009;137:869-874
© 2009 The American Association for Thoracic Surgery


Acquired Cardiovascular Disease

Bilateral internal thoracic artery on the left side: A propensity score–matched study of impact of the third conduit on the right side

Michele Di Mauro, MD, Marco Contini, MD, Angela L. Iacò, MD, Antonio Bivona, MD, Massimo Gagliardi, MD, Egidio Varone, MD, Paolo Bosco, MD, Antonio M. Calafiore, MD*

Department of Cardiac Surgery, University of Catania, Catania, Italy

Received for publication July 11, 2008; revisions received August 25, 2008; accepted for publication September 3, 2008.

* Address for reprints: Antonio M. Calafiore, MD, Chief of Department of Cardiac Surgery, University of Catania, Ferarrotto Hospital, Via Citelli, 95124, Catania, Italy. (Email: mdimauro{at}unich.it).

Objective: This study was undertaken to evaluate long-term results of bilateral internal thoracic artery grafting with saphenous vein or another arterial conduit as the third conduit.

Methods: From September 1991 to December 2002, a total of 1015 patients underwent first isolated coronary artery bypass grafting for triple-vessel disease, with bilateral internal thoracic artery plus saphenous vein in 643 cases and bilateral internal thoracic artery plus arterial conduit in 372. A nonparsimonious regression model was built to determine propensity score, then sample matching (saphenous vein vs arterial conduit) was performed to select 885 patients (590 with saphenous vein, 295 with arterial conduit). Groups had similar preoperative and operative characteristics.

Results: Eight-year freedoms from cardiac death were significantly higher when saphenous vein was used (98.6% ± 0.5% with saphenous vein vs 95.3% ± 1.3% with arterial conduit, P = .009), but this difference was related exclusively to right gastroepiploic artery grafting (94.5% ± 1.6% vs saphenous vein, P = .004). This difference disappeared for radial artery grafting (97.6% ± 1.6% vs saphenous vein, P = .492). Cox analysis confirmed that supplementary gastroepiploic artery was an independent variable for lower freedoms from all-cause mortality and from cardiac death. Presence of high-degree stenosis (80%) appeared to influence this result.

Conclusions: In patients with triple-vessel disease undergoing first isolated coronary artery bypass grafting, supplementary venous grafts seem to provide more stability than gastroepiploic artery, which may even impair long-term outcome.



Abbreviations and Acronyms AC = arterial conduit; AMI = acute myocardial infarction; BITA = bilateral internal thoracic artery; CABG = coronary artery bypass grafting; CI = confidence interval; ITA = internal thoracic artery; RA = radial artery; RCA = right coronary artery; RGEA = right gastroepiploic artery; ROC = receiver operating characteristic; SV = saphenous vein








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The American Association for Thoracic Surgery.